ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 28 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,789 | -80.1% | 4,970 | -65.6% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 14,432 | -30.1% | 0.00% | – |
| Q2 2022 | $10,000 | -41.2% | 20,632 | +7.8% | 0.00% | – |
| Q1 2022 | $17,000 | -22.7% | 19,132 | -3.7% | 0.00% | – |
| Q4 2021 | $22,000 | -26.7% | 19,862 | +19.1% | 0.00% | – |
| Q3 2021 | $30,000 | – | 16,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |